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of differential methylation in genomic regions 
using the Infinium HumanMethylation450 Assay
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Abstract 
Background: DNA methylation at cytosine nucleotides constitutes epigenetic gene regulation impacting cellular 
development and a wide range of diseases. Cytosine bases of the DNA are converted to 5-methylcytosine by the 
methyltransferase enzyme, acting as a reversible regulator of gene expression. Due to its outstanding importance in 
the epigenetic field, a number of lab techniques were developed to interrogate DNA methylation on a global range. 
Besides whole-genome bisulfite sequencing, the Infinium HumanMethylation450 Assay represents a versatile and 
cost-effective tool to investigate genome-wide changes of methylation patterns.
Results: Analysis of DNA Methylation In genomic REgions (ADMIRE) is an open source, semi-automatic analysis pipe-
line and visualization tool for Infinium HumanMethylation450 Assays with a special focus on ease of use. It features 
flexible experimental settings, quality control, automatic filtering, normalization, multiple testing, and differential 
analyses on arbitrary genomic regions. Publication-ready graphics, genome browser tracks, and table outputs include 
summary data and statistics, permitting instant comparison of methylation profiles between sample groups and the 
exploration of methylation patterns along the whole genome. ADMIREs statistical approach permits simultaneous 
large-scale analyses of hundreds of assays with little impact on algorithm runtimes.
Conclusions: The web-based version of ADMIRE provides a simple interface to researchers with limited program-
ming skills, whereas the offline version is suitable for integration into custom pipelines. ADMIRE may be used via our 
freely available web service at https://bioinformatics.mpi-bn.mpg.de without any limitations concerning the size of a 
project. An offline version for local execution is available from our website or GitHub (https://github.molgen.mpg.de/
loosolab/admire).
© 2015 Preussner et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Several epigenetic mechanisms control gene expression 
in cells [1]. One of these conserved mechanisms is DNA 
methylation, a process where cytosine bases of DNA 
are converted to 5-methylcytosine by the DNA meth-
yltransferase (DNMT) enzymes. DNA methylation by 
these enzymes is a reversible regulator of gene expres-
sion. Methylated cytosine recruits proteins which are 
involved in gene repression and inhibit the binding of 
transcription factors. The pattern of DNA methylation in 
the genome undergoes changes during development and 
plays a role in a range of diseases, utilizing processes of 
de novo methylation and demethylation. In case of devel-
opment and differentiation, differentiated cells display 
a stable, cell-type-specific methylation pattern, perma-
nently switching off the expression of genes that are not 
essential for the respective cell type.
A number of lab techniques were developed to inter-
rogate DNA methylation including whole-genome 
bisulfite sequencing (WGBS) and Infinium Human-
Methylation450 Assays [2]. Although WGBS provides a 
comprehensive genome-wide coverage (around 28 mil-
lion CpGs in humans), it is associated with relatively 
high costs for re-sequencing the whole genome. A simi-
lar method known as reduced representation bisulfite 
sequencing (RRBS) is intended to overcome this problem 
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by sequencing just DNA fragments enclosing at least 
one CpG site. While Infinium HumanMethylation450 
Assays reveal a less comprehensive picture compared to 
sequencing-based methods (approximately 0.5 million 
CpGs are addressed), economical factors render them 
highly attractive for epigenome-wide association studies 
(EWAS) involving up to thousands of individual samples 
[3] and represent an effective tool to identify biomarkers 
of disease states and progression [4].
Although Infinium HumanMethylation450 Assays are 
widely used, just very recently a cohort of noncommer-
cial analysis pipelines was introduced. However, most 
of these tools are designed as command line tools. This 
is frequently accompanied with complex usage require-
ments which pose a significant challenge to research-
ers with limited programming skills. Furthermore, the 
genome-wide visualization of methylation sites, the 
visualization of significantly differentially methylated 
sites and downstream analyses have not been addressed 
optimally, yet. Here we introduce ADMIRE, an easy to 
use web-based tool intended to simplify usage inside a 
comprehensive application accessible by web interface as 
well as programmatically. ADMIRE generates publica-
tion-ready graphical overviews of differentially methyl-
ated loci and genome-wide overview tracks (Additional 
file 1) including advanced statistical methods to increase 
sensitivity. An included gene set enrichment analysis 




Very recently, a cohort of noncommercial analysis pipe-
lines was introduced and a current selection of widely 
used packages is reviewed in [5]. While the total num-
ber of tools intended to perform at least individual steps 
of HumanMethylation450 assay analysis is estimated to 
be around 20, only a minority is accessible via a graphi-
cal user interface and often limited to specific operat-
ing systems. A detailed comparison of tool features 
is listed in Additional file  2. An easy to use web-based 
application is only provided by RnBeads [6], although 
this might be the best way for biologists with limited 
programming skills to access an analysis pipeline. In 
contrast to RnBeads (restricted to 24 arrays), the web-
based version of ADMIRE does not restrict the number 
of input arrays and was tested with a sample set of 689 
arrays from a GEO dataset described below. Addition-
ally, since calculation of per-probe test statistics is the 
main computational task (see algorithm description 
below), the runtime of ADMIRE is virtually independ-
ent of the number of input arrays. While most of the 
available tools provide functions for probe filtering and 
normalization, only a small number include functional-
ity to create scalable visualizations or to detect differen-
tially methylated positions and regions simultaneously. 
Furthermore, regions of interest are often pre-calculated 
and only a small number of tools allow statistics on indi-
vidual regions of interest that can be provided by the 
user. Finally, none of the available tools provides a down-
stream analysis that is able to discover the linkage of dif-
ferentially methylated genes. In order to generate a tool 
that combines all these critical features, we developed 
ADMIRE, a web-based tool for users without any com-
putational background.
ADMIREs calculation of test statistics
ADMIRE features five different normalization methods 
(see [7]) but can also work on raw methylation values. 
The pipeline performs two one-sided two-sample rank 
tests (Mann–Whitney U tests) based on the sample_
group information provided. In contrast to the t test, the 
Mann–Whitney U test does not require normally distrib-
uted data. The one-sided two-sample tests are performed 
per Illumina probe on the array and between pairs of 
sample groups. Intentionally, two p values are obtained 
for each probe, indicating a higher probe methylation in a 
distinct group and allowing the subsequent combination 
of multiple single p values from within a genomic region 
of interest (tiles, promotors and the like) as suggested in 
[8]. The spatially correlated p values are combined with 
genomic regions by mapping probe specific p values onto 
pre-calculated or user-defined genomic regions, indi-
cating no change or a higher methylation in either sam-
ple group. To create a p value for an entire region, the 
Stouffer–Liptak correction implemented in [9] is used. 
A 1-step Sidak correction for multiple testing is applied 
to obtain q-values (see [9]). In order to filter significantly 
differentially methylated regions, a user-defined q-value 
threshold is used.
The web‑based analysis platform
The ADMIRE analysis platform is implemented as a web-
based application (Fig. 1) and enables users with limited 
bioinformatics background to apply sophisticated meth-
ylation analysis. The web-based platform allows user 
accounts with the possibility to keep raw files and ana-
lyzed data in a workspace of unlimited size. The default 
output of a scanner system compatible to Illumina 
HumanMethylation450 Assay consists of a SampleSheet.
csv file and a file directory named after the assays Sen-
trix-ID containing two compressed *.idat-files per sam-
ple. These raw files are supported by ADMIRE. Besides 
the original SampleSheet.csv, ADMIRE is also able to 
process a tab-separated sample definition file (see user 
manual, Additional file 3).
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The settings file defines the groups that should be 
used for statistical testing. An all-vs-all comparison is 
performed with no limitation on the number of sample 
groups. Next, a wide range of analysis parameters can be 
adjusted, such as normalization method (SWAN, Func-
tional, Quantile, Noob or Illumina), quality control filter-
ing based on detection p values, failed sample threshold, 
Q-value cutoff for multiple testing as well as genomic 
regions for testing. A set of pre-calculated genomic 
regions are provided such as genome-wide tilings, anno-
tations based on Gencode [10], as well as CpG islands and 
Fantom5 enhancers [11]. Furthermore, custom regions of 
interest can be uploaded to combine probes. To gener-
ate high-resolution graphics of differentially methylated 
regions, a numeric parameter is available to choose the 
number of graphics that will be generated from the most 
significantly altered regions. If the user is interested in a 
downstream analysis of differentially regulated regions, 
a gene set enrichment analysis can be performed on a 
selection of pre-defined gene sets [12] including chro-
mosomal locations, pathways, diseases, and GO-terms. 
In addition to pre-defined sets, custom gene sets can be 
provided.
Workflow
Once the analysis is started, ADMIRE evaluates the sam-
ple definition file and prints out an error message in case 
files are missing or cannot be read. The raw files are pre-
processed and filtered by the functions from the R pack-
age minfi [7], according to the parameters set. Aggregated 
Fig. 1 Graphical user interface for the ADMIRE pipeline. On the left side a set of helpful tools for file preparation and upload is listed. The center pane 
shows the ADMIRE parameters. Most parameters can be selected from drop down menus. Input and output files are listed in the right pane
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data is used to generate a quality control report in PDF 
format and normalized beta and m values are provided 
as tabular data (Fig.  2, step 1). In accordance to the 
groups defined earlier, all-vs-all pairwise comparisons of 
per-probe methylation are performed automatically. To 
call the significant differences in terms of methylation, 
ADMIRE performs statistical tests as described in the 
section above (Fig. 2, step 2).
Next, spatially correlated p values are combined with 
respect to the genomic regions defined by the user [9]. 
The generated result list includes all genomic regions, 
sorted by significance of methylation changes between 
the groups specified and the min/max/median change of 
methylation rate is calculated for further filtering (Fig. 2 
step 3). For the most significant differentially methylated 
regions, a high-resolution image is generated (see Addi-
tional file 1). Finally, all results are transformed into BED 
format data tracks to allow visualization of differentially 
methylated regions in commonly used genome viewers 
such as IGV [13] or UCSC [14] (Fig. 2, step 4). Addition-
ally, the output includes comma-separated tables that 
can be used to filter for specific genes, genomic loca-
tions, coverage, min/max/median change, p values, and/
or q values. Details on the output files can be found in 
the methods section and in Additional file 3. Given that 
regions with a direct link to genes (indicated by a gene_
name property) were chosen as regions of interest, a 
gene set enrichment analysis can be performed [12]. The 
enrichment analysis calculates an enrichment score (ES) 
for each gene set, depending on the ranks and differences 
in methylation of genes that are members of the gene set. 
In combination with graphs for enrichment score calcu-
lations, it can be inferred whether higher methylation in 
controls or cases contributed most to the enrichment of 
the gene set. Additionally, a heat map graphically repre-
sents a leading edge analysis that allows the detection of 
gene sets with a high overlap of core genes that mainly 
affect the ES (Fig. 2, step 5). All results listed above are 
generated in the workspace and can be downloaded as 
individual files or as a compressed archive from the web-
based platform.
Performance evaluation and comparison to the existing 
gold standard
To demonstrate the ease of use, the robustness and appli-
cability of ADMIRE, we downloaded 689 HumanMeth-
ylation450 Assay samples from a study analyzing DNA 
methylation as an intermediary of genetic risk in rheu-
matoid arthritis (GEO GSE42861) [15]. ADMIRE was 
invoked from the web interface using a custom sample-
definition file (see “Methods”) with default parameters. 
We selected all 2-kB promoter regions and chose posi-
tional gene sets as input for the enrichment analysis. 
Since the runtime of ADMIRE is virtually independent 
of input size, the results were obtained after 24 h with a 
maximum memory usage of 65 GB RAM. As the analy-
sis in [15] was performed on single methylation sites and 
we did not intent to replicate the analysis, validation was 
done via an unbiased gene set enrichment analysis using 
positional gene sets as input. We identified the constant 
(TRAC) and variable (TRAV/TRAJ) segments of the 
T-cell receptor alpha chain on chr14q11 locus as higher 
methylated in arthritis patients. Additionally, four known 
members of the T-cell receptor signaling pathway, CD28, 
CD3G, CD3D as well as PDCD1, were found to be higher 
methylated in patients (Fig. 3).
In order to compare ADMIRE to RnBeads, the current 
gold standard for HumanMethylation450 Assay analysis, 
we used an additional dataset of smaller size since the 
RnBeads [16] web interface is restricted to 24 samples. 
Our test dataset contains 11 samples from a study analyz-
ing permanent atrial fibrillation (GEO GSE62727). This 
dataset was analyzed by RnBeads using default param-
eters (5-kB pre-calculated tiling regions) as well as the 
ADMIRE pipeline. To match the output from RnBeads 
and enable a direct comparison, we selected all 5-kB tiling 
regions as input for ADMIRE (see “Methods”). Our tool 
found twenty 5-kB regions corresponding to protein cod-
ing genes to be higher methylated in fibrillating atria (see 
Additional file 4) with a median methylation change of up 
to 12 %. Next, we carried out a second run with ADMIRE 
using 10-kB tiling regions as input to test for repro-
ducibility of statistically significantly changed regions. 
Besides nine genes present in both result files, another 
14 genes were identified from 10-kB regions only, with 
a median methylation change up to 45 % (see Additional 
file  5). RnBeads identified only one region to be higher 
methylated in fibrillating atria. This genomic location 
was not reported by ADMIRE. Some representative sig-
nificant regions found by ADMIRE and the single region 
found by RnBeads are shown in Fig.  4a–f. We chose an 
indirect way to evaluate specificity and significance of 
regions reported by ADMIRE but not by RnBeads. To 
evaluate the latter, we visualized the homogeneity of the 
methylation change over all 5-kB tiling regions detected 
by ADMIRE in Fig. 4g. The boxplots represent all single 
methylation sites, combined in accordance to the tiling 
region. Their level and spread present a global overview 
in order to investigate the magnitude of the methyla-
tion changes. The user can interpret this information to 
select an appropriate threshold. To evaluate the specific-
ity of our findings, we performed a functional analysis. 
This showed an enrichment of transcriptional regulation, 
driven by transcription factors such as HOX A, TBX5, 
and PITX2 (Additional file 6). This is remarkable, as ini-
tial GWAS studies identified a major risk region where 
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2  Perform one-sided two-sample tests
3  Combine spatially correlated p-values with genomic regions






















Fig. 2 Workflow is illustrated on the left side as five steps. Step 2 Controls and cases are illustrated as replicates with methylated (black) and 
unmethylated (white) CpG sites. Single sites are compared between controls and cases (dashed lines). Step 3 Site-specific p values are combined into 
genomic regions and a representative q value is calculated for each region (light gray: higher methylation in control; dark gray: higher methylation 
in cases). Step 4 IGV screenshot of array visualization; tracks represent: (I.) single CpG site q values for two conditions with a color code, (II.) positions 
of known genes, (III.), selected regions of interest, (IV.) significant regions found by the pipeline, (V.) all probes represented on the array, and (VI.) bar 
plot track denoting absolute methylation change (up/down). Step 5 An optional gene set enrichment analysis (GSEA) can be performed using pre-
defined or custom gene sets and ranked lists of differentially methylated genes
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the presence of a variant increased the risk of AF up to 
65 %. Located proximally to the variant, PITX2 is a tran-
scription factor import for cardiogenesis, especially for 
left–right signaling and L/R atrial identity. Knockout of 
PITX2 lead to a shortened atrial action potential in hap-
loinsufficient mice and increased the susceptibility to AF 
[17]. Expression analysis identified the Sinoatrial node 
(SAN) specific genes Shox2, Tbx3, and Hcn4 as upregu-
lated in PITX2 null-mutant embryos [18]. A recent study 
additionally identified two microRNAs miR-17-92 and 
miR-106b-25 as direct targets of PITX2 that can repress 
Shox2 and Tbx3 upon transcription [19] and promote the 
expression of Cx43, a connexin protein forming gap junc-
tions that allow the interchange of charged ions between 
adjacent cells [20]. Another GWAS study linked TBX5 to 
AF [21]. The homeobox transcription factor may play a 
role in heart development and specification of limb iden-
tity [22]. Interestingly, TBX5 was identified as interac-
tor of Tbx3, a regulator of the SAN gene program [23]. 
Hoxa3 is another important gene in heart chamber mor-
phogenesis, since Hoxa3-expressing progenitor cells in 
the second heart field give rise to the atria and parts of 
the outflow tract [24].
Summarizing these findings, we conclude that using 
genome-wide tiling regions as well as the positional gene 
sets in the implemented gene set enrichment provide a 
powerful and yet unbiased downstream analysis option 
to the user. As shown by the comparison to RnBeads, we 
assume ADMIRE to have a higher sensitivity to detect 
small changes in methylation rate, as the user can decide 
upon appropriate thresholds for absolute difference in 
methylation. Both datasets used for performance evalua-
tion are available as shared data libraries on the ADMIRE 
web server (see Additional file 3 for loading shared data 
libraries).
Discussion
Integration and differential analysis of DNA methyla-
tion represents a major topic in clinical bioinformat-
ics, most often addressed by whole-genome bisulfite 
sequencing or Infinium HumanMethylation450 Assays. 






















Fig. 3 Methylation of members of the T-cell receptor signaling pathway in rheumatic arthritis (Patients) vs. healthy individuals (Normal). Shown are 
the beta values from all methylation sites of 2-kb upstream regulatory regions across all 689 replicates. Black dots represent boxplot outliers
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Fig. 4 IGV screenshots showing methylation across several genomic locations and boxplots for all significant sites. a–f Tracks shown are as follows: I. 
Methylation sites present on the HumanMethylation450 K Chip, II. Color-coded methylation values from control samples, III. Color-coded methyla-
tion values from AF samples, IV. Differentially methylated 10-kbp tiling regions called by ADMIRE, V. Differentially methylated 5-kbp tiling regions 
called by ADMIRE. The color bar encodes the m value, with blue indicating low methylation values and red indicating high methylation values. The 
absolute scale is created indvidually for each bar. Track IV and V are only used if the search with the corresponding input (5- or 10-kB tiling size) 
resulted in a significant region. a A 5-kbp region from chr17 called to be differentially methylated by RnBeads with an adjusted p value of 0.00008. 
b–f Top 5 differentially methylated regions from Admire with q values between 0.0004 and 0.003. g Boxplots for 20 significantly changed protein 
coding genes (higher in AF sample) identified by ADMIRE. Each box illustrates the distribution of absolute differences of the methylation values in 
the respective significantly changed region (see also Additional file 4). The cutoff at median methylation value of 5 % is shown as red dashed line
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the analysis tools developed in the past are primarily 
focused on command line-based programming librar-
ies, such as the R-based ChAMP [25] or minfi [7] pack-
ages, limiting the use of these tools to users with at least 
some programming skills. A second group of tools are 
intended to provide a comprehensive graphical inter-
face to the user, including MethLAB [26], COHCAP 
[27], EpiDiff [28], and the Genome Studio (Illumina, 
proprietary license). Within this group, only two tools 
are available (RnBeads and ADMIRE) that are capa-
ble to provide their service not only on the command 
line but also as a web-based graphical user interface. 
While all of these programs are arguably valuable con-
tributions to facilitate the analysis of Illumina Human-
Methylation450 Assays, many may be too demanding 
to wet lab researchers and clinicians with limited com-
putational skills. To face these needs, a web frontend 
might impose the least number of restrictions to the 
user. The intuitive, interactive, and relatively simple 
interface of ADMIRE facilitates the upload, analysis, 
and visualization of a complex technology. The input is 
limited to the raw files, a sample sheet describing the 
groups of interest and the selection of a few parame-
ters. Common experimental setups in molecular stud-
ies that define more than two groups are addressed by 
automated all-vs-all comparisons. Genomic regions 
and gene sets are available as precomputed files, but 
the possibility to upload custom files offers a vari-
ety of downstream analysis options. Unfortunately, 
public web services frequently perform very limited 
in terms of throughput, since the workload has to be 
managed by the website provider. In case of Human-
Methylation450Assays, the web-based analysis from 
RnBeads is limited to 24 arrays. In contrast, the algo-
rithm of ADMIRE is designed to transfer the compu-
tational effort to the number of probes that are tested 
and is influenced only in a minor grade by the number 
of arrays under investigation. This focus permits the 
provision of the web service not only for small projects 
with a limited number of arrays, but also for large pro-
jects encompassing hundreds of input samples (per-
formance evaluation with 689 input samples). Results 
from the original publication [15] handling these 
arrays, identify the MHC region as a major genetic risk 
loci in rheumatic arthritis. MHC peptides are bound 
by T-cell receptors together with their co-receptors 
CD28 and CD3. ADMIRE highly supports this result, 
by linking differential methylation in the T-cell recep-
tor signaling pathway as an alternative mechanism to 
rheumatic arthritis. Furthermore, the differential meth-
ylation of PDCD1 (PD-1), a co-inhibitor of the T-cell 
receptor signaling pathway involved in T-cell activation 
[29] could represent another mechanism by disturbing 
the control of autoimmunity.
Conclusion
ADMIRE offers an intuitive interface to analyze DNA 
methylation patterns based on Infinium HumanMethyla-
tion450 Assays. Whereas most existing analysis tools are 
designed to be used on the command line, ADMIRE pro-
vides an easy to use web-based service as well as a version 
for local execution. A wide range of experimental and sta-
tistical settings can be adjusted, including normalization 
methods and detection of differentially methylated posi-
tions and regions. Whereas these regions are often pre-
calculated in other tools, ADMIRE can calculate statistics 
on individual regions of interest provided by the user. As 
an optional step towards downstream analysis, ADMIRE 
additionally implements a gene set enrichment procedure. 
ADMIRE is freely accessible without a limit on experi-
mental size at https://bioinformatics.mpi-bn.mpg.de.
Methods
Implementation
ADMIRE was implemented in Bash, R, and Python while 
making use of the open-source Bioconductor package 
minfi [7] and the comb-p [9] tool for data processing. 
Additionally, a variant of GSEA [12] is fully implemented 
in ADMIRE for gene set enrichment analysis. The pipe-
line was integrated into a Galaxy-based [30] platform 
similar to MIRPIPE [31] to provide online access but is 
also available for download and local execution. Input 
data can either be used immediately from Infinium 
HumanMethylation450 Assay compatible scanner sys-
tems (SampleSheet.csv and *.idat-files) or the sample file 
can be prepared as a tab-separated text file. A detailed 
explanation of all input and output files is available in 
Additional file 3.
Generation of genetic regions and gene sets
Gene information from the GENCODE V19 [10] anno-
tation was used to extract genomic regions for all exons 
(GTF feature type exon) and all 2-kB promoter regions 
downstream of the TSS. CpG islands were extracted from 
the Bioconductor annotation package IlluminaHuman-
Methylation450kanno.ilmn12.hg19. Enhancer informa-
tion was downloaded from the Fantom5 project web site 
[11]. Bedtools makewindows function was used to gener-
ate genome-wide tiling regions of different sizes ranging 
from 50 bp up to 100 kB. All genomic regions were saved 
as bed files, keeping the gene_name property, if appli-
cable. Gene sets for gene set enrichment analysis were 
downloaded from MSigDB [12] and are contained in the 
distribution of ADMIRE.
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Benchmark and analysis of publicly available datasets
All raw *.idat-files were downloaded from the respective 
GEO project site (GSE42861 and GSE62727). Tabular 
sample definition files were generated (see user manual). 
Admire was invoked using default parameters and the 
following genomic regions and gene sets: 2-kB promoter 
regions and positional gene sets for the rheumatic arthri-
tis (RA) data and 5- and 10-kB genomic tiling regions for 
the atrial fibrillation (AF) data. Results from the RA data 
were limited to contain only protein coding genes and 
TR_C/TR_J genes with a Q-value below 0.01 and an abso-
lute median difference in methylation between normal 
and patient samples of 5 % (Additional file 7). Remaining 
genes with higher methylation in patients were subjected 
to a GO analysis with two unranked lists of genes using 
GORILLA [32] (Additional file  8) and methylation val-
ues for significantly altered genes that map to the T-cell 
receptor signaling pathway were plotted in Fig. 3. Results 
from the AF data (Additional file 4) were annotated with 
their nearest gene using bedtools closest function and 
were limited to contain only protein coding genes with 
a median absolute difference of 5  %. Gene names were 
subjected to a GO analysis as described above. To ana-
lyze the sensitivity of ADMIRE, per-probe absolute dif-
ferences were extracted using bedtools map function and 
plotted per chromosomal location in Fig. 4g.
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